Global and United States Gene Delivery System Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Market Analysis and Insights: Global and United States Gene Delivery System Market
This report focuses on global and United States Gene Delivery System market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Gene Delivery System market size is estimated to be worth US$ 9197.1 million in 2022 and is forecast to a readjusted size of US$ 39700 million by 2028 with a CAGR of 27.6% during the review period. Fully considering the economic change by this health crisis, by Type, Viral Gene Delivery System accounting for % of the Gene Delivery System global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Neurological Diseases was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.

Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.

Global Gene Delivery System Scope and Market Size
Gene Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gene Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Gene Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Gene Delivery System market is segmented into
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Segment by Application, the Gene Delivery System market is segmented into
    Neurological Diseases
    Cancer
    Others

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Gene Delivery System Market Share Analysis
Gene Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Gene Delivery System business, the date to enter into the Gene Delivery System market, Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

 1 Study Coverage
    1.1 Gene Delivery System Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Gene Delivery System Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Gene Delivery System Market Size for the Year 2017-2028
        1.2.2 Global Gene Delivery System Market Size for the Year 2017-2028
    1.3 Gene Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Gene Delivery System in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Gene Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Gene Delivery System Market Dynamics
        1.4.1 Gene Delivery System Industry Trends
        1.4.2 Gene Delivery System Market Drivers
        1.4.3 Gene Delivery System Market Challenges
        1.4.4 Gene Delivery System Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Gene Delivery System by Type
    2.1 Gene Delivery System Market Segment by Type
        2.1.1 Viral Gene Delivery System
        2.1.2 Non-viral Gene Delivery System
    2.2 Global Gene Delivery System Market Size by Type (2017, 2022 & 2028)
    2.3 Global Gene Delivery System Market Size by Type (2017-2028)
    2.4 United States Gene Delivery System Market Size by Type (2017, 2022 & 2028)
    2.5 United States Gene Delivery System Market Size by Type (2017-2028)

 3 Gene Delivery System by Application
    3.1 Gene Delivery System Market Segment by Application
        3.1.1 Neurological Diseases
        3.1.2 Cancer
        3.1.3 Others
    3.2 Global Gene Delivery System Market Size by Application (2017, 2022 & 2028)
    3.3 Global Gene Delivery System Market Size by Application (2017-2028)
    3.4 United States Gene Delivery System Market Size by Application (2017, 2022 & 2028)
    3.5 United States Gene Delivery System Market Size by Application (2017-2028)

 4 Global Gene Delivery System Competitor Landscape by Company
    4.1 Global Gene Delivery System Market Size by Company
        4.1.1 Top Global Gene Delivery System Companies Ranked by Revenue (2021)
        4.1.2 Global Gene Delivery System Revenue by Player (2017-2022)
    4.2 Global Gene Delivery System Concentration Ratio (CR)
        4.2.1 Gene Delivery System Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Delivery System in 2021
        4.2.3 Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Gene Delivery System Headquarters, Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Gene Delivery System Headquarters and Area Served
        4.3.2 Global Gene Delivery System Companies Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Gene Delivery System Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Gene Delivery System Market Size by Company
        4.5.1 Top Gene Delivery System Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Gene Delivery System Revenue by Players (2020, 2021 & 2022)

 5 Global Gene Delivery System Market Size by Region
    5.1 Global Gene Delivery System Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Gene Delivery System Market Size by Region (2017-2028)
        5.2.1 Global Gene Delivery System Market Size by Region: 2017-2022
        5.2.2 Global Gene Delivery System Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Gene Delivery System Market Size YoY Growth 2017-2028
        6.1.2 North America Gene Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Gene Delivery System Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Gene Delivery System Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Gene Delivery System Market Size YoY Growth 2017-2028
        6.3.2 Europe Gene Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Gene Delivery System Market Size YoY Growth 2017-2028
        6.4.2 Latin America Gene Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Gene Delivery System Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Gene Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Biogen
        7.1.1 Biogen Company Details
        7.1.2 Biogen Business Overview
        7.1.3 Biogen Gene Delivery System Introduction
        7.1.4 Biogen Revenue in Gene Delivery System Business (2017-2022)
        7.1.5 Biogen Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Gene Delivery System Introduction
        7.2.4 Novartis Revenue in Gene Delivery System Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Company Details
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Gene Delivery System Introduction
        7.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2017-2022)
        7.3.5 Gilead Sciences Recent Development
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Company Details
        7.4.2 Sarepta Therapeutics Business Overview
        7.4.3 Sarepta Therapeutics Gene Delivery System Introduction
        7.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2017-2022)
        7.4.5 Sarepta Therapeutics Recent Development
    7.5 Alnylam Pharmaceuticals
        7.5.1 Alnylam Pharmaceuticals Company Details
        7.5.2 Alnylam Pharmaceuticals Business Overview
        7.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
        7.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2017-2022)
        7.5.5 Alnylam Pharmaceuticals Recent Development
    7.6 Amgen
        7.6.1 Amgen Company Details
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Gene Delivery System Introduction
        7.6.4 Amgen Revenue in Gene Delivery System Business (2017-2022)
        7.6.5 Amgen Recent Development
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Company Details
        7.7.2 Spark Therapeutics Business Overview
        7.7.3 Spark Therapeutics Gene Delivery System Introduction
        7.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2017-2022)
        7.7.5 Spark Therapeutics Recent Development
    7.8 Akcea Therapeutics
        7.8.1 Akcea Therapeutics Company Details
        7.8.2 Akcea Therapeutics Business Overview
        7.8.3 Akcea Therapeutics Gene Delivery System Introduction
        7.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2017-2022)
        7.8.5 Akcea Therapeutics Recent Development
    7.9 bluebird bio
        7.9.1 bluebird bio Company Details
        7.9.2 bluebird bio Business Overview
        7.9.3 bluebird bio Gene Delivery System Introduction
        7.9.4 bluebird bio Revenue in Gene Delivery System Business (2017-2022)
        7.9.5 bluebird bio Recent Development
    7.10 Sunway Biotech
        7.10.1 Sunway Biotech Company Details
        7.10.2 Sunway Biotech Business Overview
        7.10.3 Sunway Biotech Gene Delivery System Introduction
        7.10.4 Sunway Biotech Revenue in Gene Delivery System Business (2017-2022)
        7.10.5 Sunway Biotech Recent Development
    7.11 SIBIONO
        7.11.1 SIBIONO Company Details
        7.11.2 SIBIONO Business Overview
        7.11.3 SIBIONO Gene Delivery System Introduction
        7.11.4 SIBIONO Revenue in Gene Delivery System Business (2017-2022)
        7.11.5 SIBIONO Recent Development
    7.12 AnGes
        7.12.1 AnGes Company Details
        7.12.2 AnGes Business Overview
        7.12.3 AnGes Gene Delivery System Introduction
        7.12.4 AnGes Revenue in Gene Delivery System Business (2017-2022)
        7.12.5 AnGes Recent Development
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Company Details
        7.13.2 Orchard Therapeutics Business Overview
        7.13.3 Orchard Therapeutics Gene Delivery System Introduction
        7.13.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2017-2022)
        7.13.5 Orchard Therapeutics Recent Development
    7.14 Human Stem Cells Institute
        7.14.1 Human Stem Cells Institute Company Details
        7.14.2 Human Stem Cells Institute Business Overview
        7.14.3 Human Stem Cells Institute Gene Delivery System Introduction
        7.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2017-2022)
        7.14.5 Human Stem Cells Institute Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Gene Delivery System Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Gene Delivery System Market Trends
    Table 3. Gene Delivery System Market Drivers
    Table 4. Gene Delivery System Market Challenges
    Table 5. Gene Delivery System Market Restraints
    Table 6. Global Gene Delivery System Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gene Delivery System Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gene Delivery System Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gene Delivery System Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gene Delivery System Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gene Delivery System Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Gene Delivery System Revenue Share by Player, 2017-2022
    Table 13. Global Gene Delivery System Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Gene Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2021)
    Table 15. Top Players of Gene Delivery System in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Gene Delivery System Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Gene Delivery System Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Gene Delivery System Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Gene Delivery System Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Gene Delivery System Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Gene Delivery System Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Gene Delivery System Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Gene Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Gene Delivery System Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Gene Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Gene Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Gene Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Biogen Company Details
    Table 31. Biogen Business Overview
    Table 32. Biogen Gene Delivery System Product
    Table 33. Biogen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 34. Biogen Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Gene Delivery System Product
    Table 38. Novartis Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Gilead Sciences Company Details
    Table 41. Gilead Sciences Business Overview
    Table 42. Gilead Sciences Gene Delivery System Product
    Table 43. Gilead Sciences Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 44. Gilead Sciences Recent Development
    Table 45. Sarepta Therapeutics Company Details
    Table 46. Sarepta Therapeutics Business Overview
    Table 47. Sarepta Therapeutics Gene Delivery System Product
    Table 48. Sarepta Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 49. Sarepta Therapeutics Recent Development
    Table 50. Alnylam Pharmaceuticals Company Details
    Table 51. Alnylam Pharmaceuticals Business Overview
    Table 52. Alnylam Pharmaceuticals Gene Delivery System Product
    Table 53. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 54. Alnylam Pharmaceuticals Recent Development
    Table 55. Amgen Company Details
    Table 56. Amgen Business Overview
    Table 57. Amgen Gene Delivery System Product
    Table 58. Amgen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 59. Amgen Recent Development
    Table 60. Spark Therapeutics Company Details
    Table 61. Spark Therapeutics Business Overview
    Table 62. Spark Therapeutics Gene Delivery System Product
    Table 63. Spark Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 64. Spark Therapeutics Recent Development
    Table 65. Akcea Therapeutics Company Details
    Table 66. Akcea Therapeutics Business Overview
    Table 67. Akcea Therapeutics Gene Delivery System Product
    Table 68. Akcea Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 69. Akcea Therapeutics Recent Development
    Table 70. bluebird bio Company Details
    Table 71. bluebird bio Business Overview
    Table 72. bluebird bio Gene Delivery System Product
    Table 73. bluebird bio Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 74. bluebird bio Recent Development
    Table 75. Sunway Biotech Company Details
    Table 76. Sunway Biotech Business Overview
    Table 77. Sunway Biotech Gene Delivery System Product
    Table 78. Sunway Biotech Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 79. Sunway Biotech Recent Development
    Table 80. SIBIONO Company Details
    Table 81. SIBIONO Business Overview
    Table 82. SIBIONO Gene Delivery System Product
    Table 83. SIBIONO Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 84. SIBIONO Recent Development
    Table 85. AnGes Company Details
    Table 86. AnGes Business Overview
    Table 87. AnGes Gene Delivery System Product
    Table 88. AnGes Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 89. AnGes Recent Development
    Table 90. Orchard Therapeutics Company Details
    Table 91. Orchard Therapeutics Business Overview
    Table 92. Orchard Therapeutics Gene Delivery System Product
    Table 93. Orchard Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 94. Orchard Therapeutics Recent Development
    Table 95. Human Stem Cells Institute Company Details
    Table 96. Human Stem Cells Institute Business Overview
    Table 97. Human Stem Cells Institute Gene Delivery System Product
    Table 98. Human Stem Cells Institute Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
    Table 99. Human Stem Cells Institute Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gene Delivery System Product Picture
    Figure 2. Global Gene Delivery System Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gene Delivery System Market Size 2017-2028 (US$ Million)
    Figure 4. United States Gene Delivery System Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Gene Delivery System Market Size 2017-2028 (US$ Million)
    Figure 6. United States Gene Delivery System Market Share in Global 2017-2028
    Figure 7. Gene Delivery System Report Years Considered
    Figure 8. Product Picture of Viral Gene Delivery System
    Figure 9. Product Picture of Non-viral Gene Delivery System
    Figure 10. Global Gene Delivery System Market Share by Type in 2022 & 2028
    Figure 11. Global Gene Delivery System Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Gene Delivery System Market Share by Type (2017-2028)
    Figure 13. United States Gene Delivery System Market Share by Type in 2022 & 2028
    Figure 14. United States Gene Delivery System Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Gene Delivery System Market Share by Type (2017-2028)
    Figure 16. Product Picture of Neurological Diseases
    Figure 17. Product Picture of Cancer
    Figure 18. Product Picture of Others
    Figure 19. Global Gene Delivery System Market Share by Application in 2022 & 2028
    Figure 20. Global Gene Delivery System Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Gene Delivery System Market Share by Application (2017-2028)
    Figure 22. United States Gene Delivery System Market Share by Application in 2022 & 2028
    Figure 23. United States Gene Delivery System Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Gene Delivery System Market Share by Application (2017-2028)
    Figure 25. North America Gene Delivery System Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Gene Delivery System Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Gene Delivery System Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. China Taiwan Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Gene Delivery System Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Colombia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gene Delivery System Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Gene Delivery System Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Biogen Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 54. Novartis Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 55. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 56. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 57. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 58. Amgen Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 59. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 60. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 61. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 62. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 63. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 64. AnGes Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 65. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 66. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Market Analysis and Insights: Global and United States Gene Delivery System Market
This report focuses on global and United States Gene Delivery System market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Gene Delivery System market size is estimated to be worth US$ 9197.1 million in 2022 and is forecast to a readjusted size of US$ 39700 million by 2028 with a CAGR of 27.6% during the review period. Fully considering the economic change by this health crisis, by Type, Viral Gene Delivery System accounting for % of the Gene Delivery System global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Neurological Diseases was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.

Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.

Global Gene Delivery System Scope and Market Size
Gene Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gene Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Gene Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Gene Delivery System market is segmented into
    Viral Gene Delivery System
    Non-viral Gene Delivery System

Segment by Application, the Gene Delivery System market is segmented into
    Neurological Diseases
    Cancer
    Others

Regional and Country-level Analysis
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Gene Delivery System Market Share Analysis
Gene Delivery System market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Gene Delivery System business, the date to enter into the Gene Delivery System market, Revenue in Gene Delivery System Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute